Taioma Plus

Medicinal product

(Invented) name

Taioma Plus

Active substance (s)

Oksikodono hidrochloridas/Naloksono hidrochloridas

Strength

40 mg/20 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02AA55, Oxycodone and naloxone

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-10-14

Date of renewal

Documents

2949_2950_Taioma Plus 20-10mg_40-20mg_pailg_atp_tab_PL_2025-10-14.docx

2949_2950_Taioma Plus 20-10mg_40-20mg_pailg_atp_tab_PZ_2025-10-14.docx

Stage

Registruotas

Controlled?

Yes

Controlled substance type

Narkotinis

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Oksikodono hidrochloridas	40 mg
Naloksono hidrochloridas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
118943	105049	1105049	lizdinė plokštelė	N56		Receptinis	LT/L/25/2950/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-10-14	Registruotas